For investors aiming to assemble a portfolio of durable, long-term holdings, the ideas of quality investing offer a useful structure. This method centers on finding companies with lasting competitive strengths, sound financial condition, and reliable earnings—businesses that can increase value through different economic periods. One organized way to find these companies is the "Caviar Cruise" stock screen, which uses numerical filters to locate firms with a record of solid revenue and profit increase, high returns on invested capital, good cash flow production, and reasonable debt. The screen seeks to distinguish outstanding businesses from the simply adequate, offering a beginning point for more detailed fundamental study.
A recent use of this screen has pointed to STERIS PLC (NYSE:STE) as a candidate deserving more detailed look. The Ireland-based supplier of infection prevention and procedural products and services for healthcare and life sciences seems to fit a number of central standards that quality investors value.
Fitting the Central Quality Filters
The Caviar Cruise method stresses continued increase, effective capital use, and financial soundness. STERIS's past results and present measurements match these supports.
-
Continued Increase: The screen demands a minimum 5% compound annual growth rate (CAGR) for both revenue and EBIT (earnings before interest and taxes) over five years. STERIS easily goes beyond this, with a revenue CAGR of 6.66% and a more notable EBIT CAGR of 12.57%. Importantly, EBIT increase has been faster than revenue increase, a central filter in the screen. This shows better operational effectiveness and pricing ability, indicating the company is not only growing sales but is doing so more profitably over time, a sign of a quality business with possible scale benefits.
-
Notable Return on Capital: A central idea of quality investing is evaluating how effectively a company produces profits from the capital put into its operations. The screen requires a Return on Invested Capital (leaving out cash, goodwill, and intangibles) over 15%. STERIS shows a number of 25.19%, well above the limit. This high ROICexgc implies management is very effective at using capital to produce returns, building significant value for shareholders and offering protection against competition.
-
Good Cash Flow and Balance Sheet Condition: Quality companies produce sufficient free cash flow and keep careful balance sheets. The screen examines this by checking the Debt-to-Free Cash Flow ratio (favoring a number under 5) and Profit Quality (the 5-year average of Free Cash Flow/Net Income, favoring above 75%). STERIS does well on both points.
- Its Debt/FCF ratio of 2.07 shows it could pay off all its debt with just over two years of current free cash flow, indicating a sound, workable financial state.
- Its average Profit Quality of 186.77% is very high, showing it turns net income into actual cash flow at a rate much greater than the accounting profit. This gives significant financial room for dividends, share repurchases, strategic purchases, or more debt decrease.
A Summary of Fundamental Condition
A look at STERIS's wider fundamental analysis report gives a top-level verification of its quality traits. The report gives STE a total fundamental score of 6 out of 10, mentioning its "excellent profitability score" along with "great financial health attributes."
Central points from the report are:
- Profitability: The company scores well on profitability measurements, with a Return on Equity (9.89%) and Profit Margin (12.15%) that do better than a big majority of similar companies in the Health Care Equipment & Supplies field.
- Financial Health: Solvency measurements are sound, backed by a strong Altman-Z score (5.23) and the positive Debt-to-FCF ratio, showing low bankruptcy danger.
- Increase & Valuation: While past revenue and EPS increase have been good, analyst forecasts for future increase are more measured. On valuation, STE's P/E ratio is viewed as "rather high" in absolute terms but is less costly than many field peers and about equal to the wider S&P 500.
Investment Points and Setting
While the numerical screen shows a favorable image, quality investing also includes qualitative assessment. STERIS works in the necessary area of infection prevention, a market with a lasting, non-cyclical increase direction pushed by aging populations, surgical numbers, and strict sterility rules in life sciences. Its global presence and full range of consumables, equipment, and services can provide a competitive edge. Still, investors must also think about possible challenges like regulatory shifts, integration dangers from past purchases, and if the present market price correctly shows its future increase path.
The Caviar Cruise screen is made to find companies with the financial signs of quality for additional study. STERIS PLC, with its good increase history, notable returns on capital, and strong balance sheet, presents a useful example that fits this thinking.
You can review other companies that meet the Caviar Cruise quality screen by viewing the full screen results here.